Literature DB >> 8206992

Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.

J Neuzil1, R Stocker.   

Abstract

Peroxidation of the lipid moieties of low density lipoproteins (LDL) is regarded as an early event in atherogenesis. Because bilirubin is a physiological reductant with antioxidant activities, we investigated its inhibitory action on the radical-mediated oxidation of LDL and plasma lipids. Exposing fresh human blood plasma to lipophilic peroxyl radicals generated from 2,2'-azobis(2,4-dimethylvaleronitrile) (AMVN) resulted in rapid oxidation of ubiquinol-10, followed by that of ascorbate and bilirubin. Plasma lipids were well protected from peroxidation as long as these three antioxidants were present, as assessed by the amounts of cholesterylester hydroperoxides formed during this period. Following consumption of these antioxidants, and in the presence of alpha-tocopherol, the rate of hydroperoxide formation increased sharply with roughly 2 molecules of cholesterylester hydroperoxides being formed for each peroxidation initiating event. Supplementation of AMVN-oxidizing plasma with exogenous bilirubin at the onset of rapid lipid peroxidation, i.e. after depletion of endogenous ubiquinol-10, ascorbate, and bilirubin, led to a halt in both hydroperoxide formation and consumption of alpha-tocopherol. When isolated LDL was incubated with AMVN, approximately 9 molecules of cholesterylester hydroperoxides were formed per peroxidation initiating event and while alpha-tocopherol was consumed. Addition of free or albumin-bound bilirubin to isolated LDL at the onset of oxidation resulted in a strong inhibition of hydroperoxide formation and alpha-tocopherol consumption, the effect being more pronounced with the free pigment. Addition of the corresponding amounts of albumin alone was without effect. In the presence of albumin-bound bilirubin, some 30% of the pigment was initially converted into biliverdin, whereas formation of this oxidation product was not observed with the free pigment. Also, the presence of bilirubin oxidase partially reversed the inhibitory activity of bilirubin on AMVN-induced LDL oxidation in the absence but not presence of albumin. An attenuation of hydroperoxide formation and a temporary increase in LDL's alpha-tocopherol concentration were observed when free- or albumin-bound bilirubin were added to AMVN-oxidizing, alpha-tocopherol-containing LDL. In contrast, hydroperoxide formation was not inhibited significantly when the albumin-bound pigment was added to oxidizing LDL after complete consumption of its alpha-tocopherol. Our results show that bilirubin inhibits oxidation of LDL lipids initiated within the lipoprotein core and indicate that this activity is mediated by interaction of the pigment with LDL's alpha-tocopherol.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206992

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

Review 1.  Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism.

Authors:  P M Schwartsburd
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

2.  Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids.

Authors:  J Neuzil; P K Witting; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.

Authors:  K Ishikawa; M Navab; N Leitinger; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction.

Authors:  Hayato Matsumoto; Kazunobu Ishikawa; Hiroyuki Itabe; Yukio Maruyama
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

5.  Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.

Authors:  Susan Cheng; Asya Lyass; Joseph M Massaro; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

6.  Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.

Authors:  Rui Zeng; Ying Yao; Min Han; Xiaoqin Zhao; Xiao-Cheng Liu; Juncheng Wei; Yun Luo; Juan Zhang; Jianfeng Zhou; Shixuan Wang; Ding Ma; Gang Xu
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

7.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

Review 8.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 9.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

10.  Protein antioxidant response to the stress and the relationship between molecular structure and antioxidant function.

Authors:  Rafael Medina-Navarro; Genoveva Durán-Reyes; Margarita Díaz-Flores; Cecilia Vilar-Rojas
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.